SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
Frank Konings(World Health Organization), Maria D. Van Kerkhove(World Health Organization), Malik Peiris(Biology of Infection), Suxiang Tong(Centers for Disease Control and Prevention), Marion Koopmans(Erasmus MC), Jairo Andrés Méndez Rico(World Health Organization), Jens H. Kuhn(National Institute of Allergy and Infectious Diseases), Belinda L. Herring(Stanford University), George F. Gao(Chinese Academy of Sciences), Sebastian Maurer‐Stroh(Agency for Science, Technology and Research), Emma B. Hodcroft(SIB Swiss Institute of Bioinformatics), Bette Korber(Los Alamos National Laboratory), Esther Hamblion(World Health Organization), Trevor Bedford(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Roger Evans(World Health Organization), Vincent J. Munster(National Institute of Allergy and Infectious Diseases), Ihab El Masry(World Health Organization - Egypt), Leo L. M. Poon(Hong Kong Science and Technology Parks Corporation), John Ziebuhr(Justus-Liebig-Universität Gießen), Richard A. Neher(University of Basel), Alexander E. Gorbalenya(Leiden University Medical Center), Juliana Almeida Leite(World Health Organization), Amal Barakat(World Health Organization), Manish Kakkar(World Health Organization), Paola Cristina Resende(Fundação Oswaldo Cruz), Túlio de Oliveira(Stellenbosch University), Bas B. Oude Munnink(Erasmus University Rotterdam), Boris Pavlin(World Health Organization), Anne von Gottberg(National Health Laboratory Service), Oliver G. Pybus(Royal Veterinary College), Mark J. Pallen(Quadram Institute), Mark D. Perkins(Louisiana State University Health Sciences Center Shreveport), Julian Druce(Victorian Infectious Diseases Reference Laboratory), Erik Alm(European Centre for Disease Prevention and Control), Jinal N. Bhiman(National Health Laboratory Service), Leon Caly(Victorian Infectious Diseases Reference Laboratory), Andrew Rambaut(University of Edinburgh), Brett N. Archer(World Health Organization), Marco Marklewitz(Institut thématique Génétique, génomique et bioinformatique), Lisa L. Carter(World Health Organization), Anne Cullinane(University of Limerick), Edward C. Holmes(The University of Sydney), Volker Thiel(University of Bern), Lorenzo Subissi(World Health Organization), Sylvie van der Werf(Centre National de la Recherche Scientifique), Duncan MacCannell(Centers for Disease Control and Prevention), Shagun Khare(World Health Organization)
Cited by 315
Related Papers
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
|Nature Microbiology|2020|7.7k
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
SARS and MERS: recent insights into emerging coronaviruses
|Nature Reviews Microbiology|2016|3.7k
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
|Nature Microbiology|2020|3.4k